Researchers Reprogram NK Immune Cells to Combat Cancer and Autoimmune Disorders

Researchers at MIT have developed a new approach using tiny engineered nanoparticles to reprogram natural killer (NK) immune cells within the body. This method shows promise in fighting cancer and autoimmune disorders by targeting diseases caused by dysfunctional T cells, such as lymphoma and autoimmune hepatitis.